Partnership
SuitX x Ottobock Acquisition
Ottobock acquired 100% of suitX shares in November 2021, integrating suitX's occupational and medical exoskeleton portfolio (backX, legX, shoulderX, Phoenix) into Ottobock Bionic Exoskeletons (Paexo). Founder Dr. Homayoon Kazerooni remained as Chief Scientist.
investment · Concluded · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/suitx-x-ottobock-acquisition.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/suitx-x-ottobock-acquisition
- Revision history: /partnerships/suitx-x-ottobock-acquisition/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
54327fb6-123d-406c-9305-76489ea562eb- Type
- investment
- Status
- Concludedoperating
- Announced
- 2021-11-034.8 years ago
- Start
- 2021-11-034.8 years ago
- Active for
- 4.8 years
Who’s involved
SuitX (US Bionics) is a California-based [Exoskeleton](/companies/exoskeleton-technologies) company spun out of the Robotics and Human Engineering Lab at UC Berkeley, founded by Dr. Homayoon Kazerooni. The company develops lightweight occupational and medical exoskeletons including backX, legX, and shoulderX modules for industrial workers, and Phoenix, an FDA-approved exoskeleton for individuals with spinal cord injuries. SuitX was acquired by Ottobock in November 2021 and now operates as Ottobock Bionic Exoskeletons (Paexo), with Kazerooni remaining as Chief Scientist.
Off-registry parties
- Ottobock · investor partner
Related partnerships
Recent partnerships of the same kind
- mizuho-financial-group x Partners GroupMizuho Financial Group + Partners Groupinvestment—operating
- investment—operating
- investment—operating
- investment—operating
- investment—operating
- investment—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.